Oncology Central

Lung cancer screening in the elderly


The National Lung Screening Trial found a 20% decrease in lung cancer-specific mortality using low-dose computed tomography to screen individuals with a 30 pack-year history of smoking, aged 55–75 years. Increasing age is an independent risk factor for lung cancer. Thus, elderly patients stand to benefit the most from low-dose computed tomography screening.

To view restricted content, please:

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.